Stock listing

GPW:NNG NanoGroup SA Akcje

Follow NanoGroup SA into a list and get an email when it puts out news.

Share price · GPW:NNG

2.03 PLN -0.03 (-1.5%)

Close on Nov 20, 2026

Past year -25.5% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
2.03 – 2.09 PLNNov 20, 2026
Volume
40,030 sharesNov 20, 2026
Market cap
86.54M PLNAt the close on Nov 20, 2026 · price × 42.63M shares outstanding
52-week range
1.98 – 3.20 PLNLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
88,268 PLNMedian day 24,721 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
NanoGroup SA logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · GPW:NNG · PLN, adjusted for splits

DayCloseChange%OpenHighLowVolume
2.03-0.03-1.5%2.042.092.0340,030
2.06+0.035+1.7%2.032.0652.02524,084
2.025-0.035-1.7%2.0252.072.0285,104
2.06-0.12-5.5%2.192.192.015169,998
2.180.000.0%2.1652.1951.978112,075
2.18-0.025-1.1%2.1652.2252.1545,120
2.205-0.04-1.8%2.252.252.15538,049
2.2450.000.0%2.2452.2752.1869,323
2.245-0.035-1.5%2.282.302.2049,401
2.28-0.01-0.4%2.302.302.287,231
2.290.000.0%2.292.2952.276,396
2.29+0.015+0.7%2.2752.292.258,334
2.275-0.075-3.2%2.3452.352.2343,660
2.350.000.0%2.372.372.2912,594
2.35-0.005-0.2%2.372.372.2910,026
2.355+0.045+1.9%2.362.362.3056,855
2.310.000.0%2.2752.3752.2757,010
2.31-0.02-0.9%2.332.3652.298,572
2.33-0.01-0.4%2.302.3352.2718,586
2.340.000.0%2.342.342.286,893
2.34-0.025-1.1%2.3752.3752.22546,746
2.365+0.005+0.2%2.352.3752.339,675
2.36-0.025-1.0%2.3452.402.3457,342
2.385+0.01+0.4%2.352.4252.3457,265
2.375-0.01-0.4%2.372.3752.34513,821
2.385+0.025+1.1%2.402.4152.3519,634
2.360.000.0%2.352.392.3522,520
2.36-0.04-1.7%2.352.452.3524,721
2.40-0.04-1.6%2.452.472.2674,544
2.44+0.025+1.0%2.392.4552.3516,776
2.415-0.015-0.6%2.4552.4552.3912,558
2.430.000.0%2.412.4752.4029,745
2.43-0.04-1.6%2.4952.4952.4016,624
2.47+0.01+0.4%2.462.472.4059,984
2.46-0.02-0.8%2.4752.4752.4418,922
2.480.000.0%2.482.4952.41512,735
2.48-0.02-0.8%2.4952.502.4325,150
2.500.000.0%2.502.502.46534,232
2.500.000.0%2.4752.502.4511,800
2.50+0.005+0.2%2.4952.502.4644,480
2.495+0.01+0.4%2.4852.502.4641,844
2.485+0.005+0.2%2.452.502.4587,614
2.48+0.015+0.6%2.492.492.4559,924
2.465-0.03-1.2%2.492.492.4357,969
2.495+0.105+4.4%2.442.522.39108,701
2.39-0.025-1.0%2.392.462.3927,638
2.415-0.045-1.8%2.4652.472.38526,476
2.46-0.03-1.2%2.512.5152.4174,907
2.49-0.015-0.6%2.472.512.4640,638
2.505-0.035-1.4%2.522.5252.44569,630
2.540.000.0%2.552.562.50105,653
2.54+0.10+4.1%2.4452.5452.41207,494
2.44+0.015+0.6%2.432.472.3727,951
2.425+0.015+0.6%2.412.492.3545,416
2.41+0.025+1.0%2.392.422.3130,167
2.385-0.055-2.3%2.4452.4752.3823,774
2.44-0.035-1.4%2.482.482.39516,303
2.475+0.03+1.2%2.4452.502.4043,932
2.445+0.04+1.7%2.4052.452.3953,706
2.405-0.025-1.0%2.4252.472.3811,226
2.43+0.05+2.1%2.432.4352.396,397
2.38-0.09-3.6%2.4752.4752.3840,146
2.47+0.005+0.2%2.462.4752.4113,005
2.465-0.03-1.2%2.4152.492.4113,147
2.495+0.005+0.2%2.4752.502.47510,505
Ticker
GPW:NNG
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
GPW
Currency
PLN

What changed lately

NanoGroup SA on 6ix

Sector
Health care
Industry
Biotechnology
Decks
3 decks · latest May 2026

Valuation

Price/book 4.0× against a median of 1.6×: 7th lowest of 9 Biotechnology companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
76.26M PLN
P/E
Loss
EV/sales
No revenue
EV/EBITDA
Negative EBITDA
Price/book
4.0×
Gross margin
No revenue
Operating margin
No revenue
Net margin
No revenue
Debt to equity
0.0×
Beta
No index for this market yet

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
NanoGroup SA · GPW:NNGUS$21.32MUS$18.78Mn/an/an/a4.0×n/a0.0×n/a
ME Therapeutics Holdings, Inc. · CSE:METXUS$22.25MUS$21.88Mn/an/an/a49.5×n/a0.0×0.52
CervoMed Inc. · NASDAQ:CRVOUS$22.09MUS$2.49Mn/a285×n/a1.3×n/a0.0×1.97
Sona Nanotech, Inc. · CSE:SONAUS$21.84MUS$22.06Mn/an/an/an/an/an/a0.47
Mendus AB · OMXSTO:IMMUUS$21.76MUS$17.65Mn/an/an/a0.4×n/a0.0×n/a
Metagenomi Therapeutics, Inc. · NASDAQ:MGXUS$21.36M−US$44.10Mn/a−6.2×n/a0.2×n/a0.4×1.65
Cel-Sci Corporation · AMEX:CVMUS$21.28MUS$14.76Mn/an/an/a1.9×n/a0.0×1.13
ZYUS Life Sciences Corporation · TSXV:ZYUSUS$20.92MUS$25.65Mn/a98.4×n/an/an/an/a-0.02
Xbrane Biopharma AB · OMXSTO:XBRANEUS$20.88MUS$23.48Mn/a1.9×n/a0.4×−49.0%0.1×n/a
Vivoryon Therapeutics N.V. · EURONEXT:VVYUS$20.48MUS$17.77Mn/an/an/a11.9×n/a0.1×n/a
Evaxion A/S · NASDAQ:EVAXUS$20.30MUS$13.40Mn/a1.8×n/a2.1×−115.1%0.8×0.78
Median of the othersUS$21.32MUS$17.71M1.9×1.6×−82.1%0.0×0.78

Team and board

DirectorRole
Jakub TatakCzłonek Rady Nadzorczej
Jerzy GarlickiPrzewodniczący Rady Nadzorczej
Łukasz GołębiewskiCzłonek Rady Nadzorczej
Piotr MierzejewskiWiceprezes Zarządu
Przemysław MazurekPrezes Zarządu
Rafał PłókarzCzłonek Rady Nadzorczej
Tadeusz WesołowskiCzłonek Rady Nadzorczej
Tomasz CiachZałożyciel, Członek Zarządu
Tomasz ZastawnyCzłonek Rady Nadzorczej

Decks

DeckKindSlidesDate
Corporate Update (May 2026)Corporate update17 slidesMay 2026
Fact Sheet (October 2020)Fact sheet3 slidesOctober 2020
IPO Roadshow (October 2017)IPO roadshow19 slidesOctober 2017

Open Decks

Financials

Annual, in PLN

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue02.10K2.02K139.5K492.5K687.5K351.8K110.3K40.8K
Cost of revenue111.5K46.6K81.0K95.8K185.9K31.2K18.3K25.6K86.8K58.4K
Gross profit-111.5K-44.5K-79.0K43.8K306.6K656.3K333.6K84.7K-46.0K-58.4K
Research and development454.6K12.1M1.20M5.11M
Selling, general and administrative1.72M848.9K711.8K1.32M1.10M456.0K
Operating income-9.58M-5.18M-7.90M-784.6K-10.6M-3.26M-1.71M-2.41M-2.01M-951.0K
Depreciation and amortization111.5K34.9K35.4K62.2K64.3K156.6K215.2K55.3K54.2K35.6K
EBITDA-9.46M-5.14M-7.87M-722.4K-10.5M-3.11M-1.49M-2.35M-1.96M-915.4K
Interest expense141.09K4.52K1.36K108.1K31.8K51.4K19.3K24.3K20.9K
Income before tax-9.58M-5.22M-7.91M-783.5K-10.7M-5.24M-1.54M-2.42M-2.03M-936.0K
Income tax34.4K0-12.0K-12.0K65.5K24.0K-5.54K-3.18K-170.8K
Net income-9.45M-5.17M-7.89M-838.6K-10.0M-5.19M-1.54M-2.34M-2.01M-786.1K
Earnings per share, basic-0.29-0.16-0.39-0.05-0.64-0.31-0.11-0.18-0.15-0.07
Earnings per share, diluted-0.33-0.04-0.61

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents15.5M7.83M537.6K2.47M4.00M10.3M1.92M4.57M5.57M9.31M
Short-term investments1.27M1.55M102.2K
Receivables548.1K205.2K57.9K57.8K523.7K540.1K7.20K6.76K14.7K
Inventory91.3K36.2K63.4K46.5K48.4K43311.2K3.30K
Current assets16.2M9.42M836.1K2.93M5.08M11.1M2.26M4.88M6.25M9.68M
Property, plant and equipment485.9K295.5K432.1K1.04M1.27M789.9K1.27M
Goodwill000002.40M4.38M5.57M5.35M5.05M
Total assets40.6M19.9M8.63M19.2M20.3M30.0M26.4M27.0M22.6M19.5M
Accounts payable588.7K100.5K194.2K202.7K280.2K130.4K75.2K94.8K1.40M187.4K
Current liabilities20.6M799.7K1.49M1.42M4.50M782.5K523.3K563.9K2.48M3.92M
Long-term debt285.3K430.7K35.1K
Total debt139.2K285.3K612.5K652.1K45.6K69.4K
Total liabilities20.6M4.01M3.47M11.4M11.9M11.3M13.1M11.5M8.44M6.70M
Shareholders' equity9.25M15.2M4.48M7.08M7.73M17.7M12.3M14.2M12.8M11.4M
Shares outstanding32.8M31.6M20.1M16.7M16.7M16.7M14.0M13.0M13.0M12.0M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-8.80M-5.72M-4.76M-3.68M-2.65M-1.35M-1.58M-3.47M-2.60M-772.1K
Capital spending-1.17M-191.9K-75.9K-8.41K-50.0K-2.17M-2.82M-5.86M-9.12M-2.08M
Free cash flow-9.97M-5.91M-4.84M-3.69M-2.70M-3.51M-4.40M-9.33M-11.7M-2.85M
Cash from investing-13.3M-4.58M-3.66M-806.9K-3.87M-2.01M-2.40M-5.86M-9.12M-2.07M
Cash from financing29.7M17.6M6.48M2.96M749.2K11.8M1.32M8.33M7.98M8.16M
Share buybacks0011.4M3.55M3.83M
Change in cash7.63M7.29M-1.93M-1.53M-5.78M8.40M-2.65M-1.00M-3.73M5.32M

Open Financials

Cap table

Built by 6ix from NanoGroup SA’s releases

Common shares
42,628,988
Fully diluted
42,628,988

Fully diluted

LineShares
Common shares42,628,988

Share count over time

CountShares
Nov 22, 202642,628,988

Open Cap table

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Jakub TatakCzłonek Rady Nadzorczej · Since at least Nov 5, 2026
Jerzy GarlickiPrzewodniczący Rady Nadzorczej · Since at least Nov 5, 2026
Łukasz GołębiewskiCzłonek Rady Nadzorczej · Since at least Nov 5, 2026
Piotr MierzejewskiWiceprezes Zarządu · Since at least Nov 5, 2026
Przemysław MazurekPrezes Zarządu · Since at least Nov 5, 2026
Rafał PłókarzCzłonek Rady Nadzorczej · Since at least Nov 5, 2026
Tadeusz WesołowskiCzłonek Rady Nadzorczej · Since at least Nov 5, 2026
Tomasz CiachZałożyciel, Członek Zarządu · Since at least Nov 5, 2026
Tomasz ZastawnyCzłonek Rady Nadzorczej · Since at least Nov 5, 2026

Open People

Log in to ask 6ix AI your own questions about NanoGroup SA.